Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
1.450
-0.010 (-0.68%)
At close: Jul 28, 2026
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $46.94 million as of August 18, 2026. Its market cap has decreased by -18.08% in one year.
Market Cap
46.94M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.45
ChartMarket Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 9.76M to 46.94M, an increase of 380.92%. That is a compound annual growth rate of 20.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 46.94M | 146,682,350.00% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 1,045.91% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 104.51M |
| HST Global | 91.93M |
| Sangamo Therapeutics | 69.72M |
| Arch Biopartners | 51.76M |
| Nuo Therapeutics | 48.41M |
| Biomind Labs | 46.54M |
| Cell Source | 44.02M |
| BetterLife Pharma | 33.50M |